Sellers back in control after the bounce from 7.6
Kyverna Therapeutics slips 4.6% as sellers retake control after the rebound
Sellers back in control after the bounce from 7.6
Our view last week
Kyverna Therapeutics is in the fifth week of a sell signal, and the week just closed gained 5.3%: a double bottom in the 7.6 area supplied the push, with an intermediate rebound of 8%. Signal strength drops to 2 out of 100, the profile of a decline running on fumes. The setup quality indicator, at 52 out of 100, stays in the ordinary band, and the stock ranks 113th among the 137 US sell signals.
This week's summary
Kyverna Therapeutics' weekly technical picture shows a 4.6% drop, after three weeks of gains had chipped away at the sell signal under management. The price found a double bottom in the 7.6 area and rebounded 8%, but sellers took back control into the close, with more than 90% of the week's volume on the sell side. The short remains down 13.6% since entry, squeezed between the 8.55 area and the 8.42 area.
IQS Phase
58
ordinary
Signal Strength
15
decline fading out
Sizing
MINIMUM
Ranking
#67 / 137
US stocks
Trade P&L %
-13.59%
from signal to today
restricted Platinum content